These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17595285)

  • 1. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
    Canut A; Martín-Herrero JE; Labora A; Maortua H
    J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Sethi S
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S177-85. PubMed ID: 15942884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute exacerbation of severe-to-very severe COPD with azithromycin in patients vaccinated against Streptococcus pneumoniae.
    Cazzola M; Salzillo A; De Giglio C; Piccolo A; Califano C; Noschese P
    Respir Med; 2005 Jun; 99(6):663-9. PubMed ID: 15878482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
    Chelidze K; Jgarkava M
    Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease.
    van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R
    Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
    Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.
    Martinez FJ; Han MK; Flaherty K; Curtis J
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):101-24. PubMed ID: 16441213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of acute otitis media pathogen shifts on the clinical efficacy of several antibiotics: a therapeutic outcomes model.
    Canut A; Martin-Herrero JE; Maortua H; Labora A; Isla A; Rodriguez-Gascon A
    J Chemother; 2009 Aug; 21(4):408-13. PubMed ID: 19622459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital.
    Larsen MV; Janner JH; Nielsen SD; Friis-Møller A; Ringbaek T; Lange P
    Scand J Infect Dis; 2009; 41(1):26-32. PubMed ID: 18855228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mathematical therapeutic outcomes model for sinusitis.
    Poole MD
    Otolaryngol Head Neck Surg; 2004 Jan; 130(1 Suppl):46-50. PubMed ID: 14726905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
    Poachanukoon O; Kitcharoensakkul M
    Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of 6-month mortality in elderly patients with mild chronic obstructive pulmonary disease discharged from a medical ward after acute nonacidotic exacerbation.
    Ranieri P; Bianchetti A; Margiotta A; Virgillo A; Clini EM; Trabucchi M
    J Am Geriatr Soc; 2008 May; 56(5):909-13. PubMed ID: 18384582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease.
    Sethi S; Anzueto A; Miravitlles M; Arvis P; Alder J; Haverstock D; Trajanovic M; Wilson R
    Infection; 2016 Feb; 44(1):65-76. PubMed ID: 26370552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers.
    Pasqua F; Biscione G; Crigna G; Cazzola M
    Ther Adv Respir Dis; 2008 Aug; 2(4):209-14. PubMed ID: 19124373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.
    Berim I; Sethi S
    Ther Adv Respir Dis; 2011 Jun; 5(3):207-16. PubMed ID: 21378062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rising to the challenge of resistance: a case study-based discussion.
    Housset B
    Int J Antimicrob Agents; 2007 Feb; 29 Suppl 1():S11-6. PubMed ID: 17307651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study.
    Roede BM; Bresser P; El Moussaoui R; Krouwels FH; van den Berg BT; Hooghiemstra PM; de Borgie CA; Speelman P; Bossuyt PM; Prins JM
    Clin Microbiol Infect; 2007 Mar; 13(3):284-90. PubMed ID: 17391383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the relationship between airway bacterial infections and acute exacerbations in patients with chronic obstructive pulmonary disease].
    Zhou YQ; Xie CM; Chen DM; Chen L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):503-6. PubMed ID: 17877185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
    Kahn JB; Khashab M; Ambruzs M
    Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.